Companies House does not verify the accuracy of the information filed

Advanced company search

CENTESSA PHARMACEUTICALS (OREXIA) LIMITED

Company number 11607013

Follow this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Company Results (links open in a new window)
Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
17 Dec 2024	GAZ2(A)	Final Gazette dissolved via voluntary strike-off	View PDF Final Gazette dissolved via voluntary strike-off - link opens in a new window - 1 page (1 page)
01 Oct 2024	GAZ1(A)	First Gazette notice for voluntary strike-off	View PDF First Gazette notice for voluntary strike-off - link opens in a new window - 1 page (1 page)
26 Sep 2024	MR05	All of the property or undertaking has been released from charge 116070130001	View PDF All of the property or undertaking has been released from charge 116070130001 - link opens in a new window - 1 page (1 page)
26 Sep 2024	MR05	All of the property or undertaking has been released from charge 116070130003	View PDF All of the property or undertaking has been released from charge 116070130003 - link opens in a new window - 1 page (1 page)
26 Sep 2024	MR05	All of the property or undertaking has been released from charge 116070130002	View PDF All of the property or undertaking has been released from charge 116070130002 - link opens in a new window - 1 page (1 page)
23 Sep 2024	DS01	Application to strike the company off the register	View PDF Application to strike the company off the register - link opens in a new window - 1 page (1 page)
21 Feb 2024	CS01	Confirmation statement made on 7 February 2024 with no updates	View PDF Confirmation statement made on 7 February 2024 with no updates - link opens in a new window - 3 pages (3 pages)
03 Oct 2023	AA	Accounts for a small company made up to 31 December 2022	View PDF Accounts for a small company made up to 31 December 2022 - link opens in a new window - 20 pages (20 pages)
31 Aug 2023	TM01	Termination of appointment of David John Grainger as a director on 18 August 2023	View PDF Termination of appointment of David John Grainger as a director on 18 August 2023 - link opens in a new window - 1 page (1 page)
22 Aug 2023	TM01	Termination of appointment of David Min Chao as a director on 18 August 2023	View PDF Termination of appointment of David Min Chao as a director on 18 August 2023 - link opens in a new window - 1 page (1 page)
28 Jul 2023	SH19	Statement of capital on 28 July 2023 EUR 1.000000	View PDF Statement of capital on 28 July 2023 EUR 1.000000 - link opens in a new window - 3 pages (3 pages)
28 Jul 2023	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
28 Jul 2023	CAP-SS	Solvency Statement dated 28/07/23	View PDF Solvency Statement dated 28/07/23 - link opens in a new window - 2 pages (2 pages)
28 Jul 2023	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Canellation of share premium account/amount credited to the reserves 28/07/2023	View PDF Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Canellation of share premium account/amount credited to the reserves 28/07/2023 - link opens in a new window - 2 pages (2 pages)
03 Apr 2023	CERTNM	Company name changed orexia therapeutics LIMITED\certificate issued on 03/04/23 NM04 ‐ Change of name by provision in articles	View PDF Company name changed orexia therapeutics LIMITED\certificate issued on 03/04/23 NM04 ‐ Change of name by provision in articles - link opens in a new window - 2 pages (2 pages)
01 Mar 2023	CS01	Confirmation statement made on 7 February 2023 with updates	View PDF Confirmation statement made on 7 February 2023 with updates - link opens in a new window - 4 pages (4 pages)
30 Jan 2023	MA	Memorandum and Articles of Association	View PDF Memorandum and Articles of Association - link opens in a new window - 10 pages (10 pages)
05 Jan 2023	PSC02	Notification of Centessa Pharmaceuticals (Uk) Limited as a person with significant control on 20 December 2022	View PDF Notification of Centessa Pharmaceuticals (Uk) Limited as a person with significant control on 20 December 2022 - link opens in a new window - 2 pages (2 pages)
05 Jan 2023	PSC07	Cessation of Centessa Pharmaceuticals Plc as a person with significant control on 20 December 2022	View PDF Cessation of Centessa Pharmaceuticals Plc as a person with significant control on 20 December 2022 - link opens in a new window - 1 page (1 page)
15 Dec 2022	CS01	Confirmation statement made on 3 December 2022 with updates	View PDF Confirmation statement made on 3 December 2022 with updates - link opens in a new window - 4 pages (4 pages)
09 Nov 2022	AP01	Appointment of Richard Menziuso as a director on 1 November 2022	View PDF Appointment of Richard Menziuso as a director on 1 November 2022 - link opens in a new window - 2 pages (2 pages)
06 Oct 2022	AA	Accounts for a small company made up to 31 December 2021	View PDF Accounts for a small company made up to 31 December 2021 - link opens in a new window - 20 pages (20 pages)
01 Aug 2022	TM01	Termination of appointment of Marella Thorell as a director on 31 July 2022	View PDF Termination of appointment of Marella Thorell as a director on 31 July 2022 - link opens in a new window - 1 page (1 page)
23 Jun 2022	AP01	Appointment of David Min Chao as a director on 17 June 2022	View PDF Appointment of David Min Chao as a director on 17 June 2022 - link opens in a new window - 2 pages (2 pages)
15 Mar 2022	SH01	Statement of capital following an allotment of shares on 14 March 2022 EUR 608.0132	View PDF Statement of capital following an allotment of shares on 14 March 2022 EUR 608.0132 - link opens in a new window - 3 pages (3 pages)

Tell us what you think of this service Is there anything wrong with this page?